122 related articles for article (PubMed ID: 3913977)
1. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. III. Analysis of the factors affecting the effectiveness of treatment with thymoleptics].
Twarowska-Hauser J; Strzyzewski W
Psychiatr Pol; 1985; 19(5):370-5. PubMed ID: 3913977
[No Abstract] [Full Text] [Related]
2. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. II. Comparison of the effects of various thymoleptics on the psychopathological symptoms of endogenous depressive syndromes].
Strzyzewski W; Twarowska-Hauser J; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
Psychiatr Pol; 1985; 19(5):363-9. PubMed ID: 3913976
[No Abstract] [Full Text] [Related]
3. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles].
Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975
[No Abstract] [Full Text] [Related]
4. [Clinical characteristics and typological classification of endogenous depression resistant to treatment].
Bondar' VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):84-8. PubMed ID: 1319660
[TBL] [Abstract][Full Text] [Related]
5. Lithium treatment of depression.
Noyes R; Dempsey GM
Dis Nerv Syst; 1974 Dec; 35(12):573-6. PubMed ID: 17896758
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
Giner Ubago J; González Infante JM; Blanco Picabia A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
[No Abstract] [Full Text] [Related]
7. [GABA levels in the plasma of patients with endogenous depression and during the treatment with thymoleptics].
Rode A; Bidziński A; Puzyński S
Psychiatr Pol; 1991; 25(3-4):4-7. PubMed ID: 1821976
[TBL] [Abstract][Full Text] [Related]
8. [Drug resistance and various selected demographic and clinical characteristics of patients with endogenous depression].
Puzyński S; Kalinowski A; Bidzińska E; Beresewicz M
Psychiatr Pol; 1990; 24(5):16-22. PubMed ID: 2131472
[TBL] [Abstract][Full Text] [Related]
9. [Changes in hormonal indicators during the treatment of depression of different types].
Krasnov VI; Kokhanenko EM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):101-5. PubMed ID: 2750367
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of depressive subtypes.
Brotman AW; Falk WE; Gelenberg AJ
Psychiatr Med; 1988; 6(3):92-113. PubMed ID: 3062675
[No Abstract] [Full Text] [Related]
11. [Influence of the seasons on the course and therapeutic results of depressive phases of maniomelancholy (author's transl)].
Sedivec V
Cesk Psychiatr; 1981 Oct; 77(5):326-30. PubMed ID: 7326778
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of a new tricyclic antidepressant iprindole.
Ayd FJ
Dis Nerv Syst; 1969 Dec; 30(12):818-24. PubMed ID: 4904943
[No Abstract] [Full Text] [Related]
13. [Pyrazidole in the treatment of endogenous depression: controlled study (author's transl)].
Zapletálek M; Libiger J; Kaspárková E; Tůma I; Domkár J
Cesk Psychiatr; 1981 Feb; 77(1):31-7. PubMed ID: 7018710
[No Abstract] [Full Text] [Related]
14. Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs.
Prien RF; Levine J
Psychopharmacol Bull; 1984; 20(2):250-7. PubMed ID: 6374721
[No Abstract] [Full Text] [Related]
15. Bipolar depression: specific treatments.
Potter WZ
J Clin Psychiatry; 1998; 59 Suppl 18():30-6. PubMed ID: 9840196
[TBL] [Abstract][Full Text] [Related]
16. [Open preliminary study of new antidepressive compound: citalopram].
Ropert R; Lôo H; Gay C
Encephale; 1984; 10(3):131-4. PubMed ID: 6594229
[TBL] [Abstract][Full Text] [Related]
17. The use of lithium to augment antidepressant medication.
Rouillon F; Gorwood P
J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of depression with melitracen].
Puzyński S; Kalinowski A
Wiad Lek; 1967 Oct; 20(20):1859-64. PubMed ID: 4868392
[No Abstract] [Full Text] [Related]
19. Some clinical and biochemical predictors of outcome in depression.
Banki CM
Adv Biochem Psychopharmacol; 1984; 39():147-51. PubMed ID: 6205558
[No Abstract] [Full Text] [Related]
20. The modern pharmacopoeia: a return to depressive realism?
Goldberg JF
Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
